| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
51,496 |
41,268 |
$1.69M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,517 |
5,502 |
$164K |
| 80305 |
|
28,032 |
22,697 |
$99K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,213 |
3,955 |
$36K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
475 |
385 |
$12K |
| 99406 |
|
2,497 |
1,819 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
158 |
140 |
$8K |
| 90756 |
|
669 |
590 |
$8K |
| 86328 |
|
173 |
139 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
381 |
234 |
$3K |
| 72100 |
|
442 |
373 |
$3K |
| 99496 |
|
47 |
28 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
256 |
224 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
60 |
45 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
265 |
225 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
536 |
409 |
$1K |
| 81002 |
|
931 |
806 |
$943.02 |
| 90686 |
|
87 |
73 |
$839.43 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
24 |
$838.53 |
| 96127 |
|
880 |
725 |
$712.60 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
23 |
18 |
$555.29 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
759 |
630 |
$501.26 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
38 |
$278.62 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
124 |
101 |
$264.28 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
87 |
81 |
$185.66 |
| 90658 |
|
13 |
12 |
$171.60 |
| 99497 |
|
89 |
69 |
$127.54 |
| 72040 |
|
16 |
13 |
$84.19 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
90 |
76 |
$80.76 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
12 |
$74.00 |
| G0008 |
Administration of influenza virus vaccine |
383 |
337 |
$73.75 |
| 90653 |
|
35 |
31 |
$50.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
25 |
$44.83 |
| 3074F |
|
1,130 |
902 |
$30.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
76 |
70 |
$25.51 |
| 90694 |
|
26 |
26 |
$0.00 |
| 99397 |
|
42 |
37 |
$0.00 |